These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Review article: the pathophysiology of gastro-oesophageal reflux disease. Boeckxstaens GE Aliment Pharmacol Ther; 2007 Jul; 26(2):149-60. PubMed ID: 17593062 [TBL] [Abstract][Full Text] [Related]
7. The role of the hiatus hernia in gastro-oesophageal reflux disease. Gordon C; Kang JY; Neild PJ; Maxwell JD Aliment Pharmacol Ther; 2004 Oct; 20(7):719-32. PubMed ID: 15379832 [TBL] [Abstract][Full Text] [Related]
8. [Ethiopathogenesis of gastroesophageal reflux disease]. Lukás K; Marecek P Cas Lek Cesk; 2000 Aug; 139(15):455-9. PubMed ID: 22666924 [TBL] [Abstract][Full Text] [Related]
9. Review article: current practice and future perspectives in the management of gastro-oesophageal reflux disease. Lambert R Aliment Pharmacol Ther; 1997 Aug; 11(4):651-62. PubMed ID: 9305472 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of gastroesophageal reflux]. Schaub N Schweiz Med Wochenschr; 1985 Jan; 115(4):114-25. PubMed ID: 2858123 [TBL] [Abstract][Full Text] [Related]
11. Gastroesophageal reflux disease in the obese: Pathophysiology and treatment. Nadaleto BF; Herbella FA; Patti MG Surgery; 2016 Feb; 159(2):475-86. PubMed ID: 26054318 [TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of gastroesophageal reflux disease: new understanding in a new era. Herregods TV; Bredenoord AJ; Smout AJ Neurogastroenterol Motil; 2015 Sep; 27(9):1202-13. PubMed ID: 26053301 [TBL] [Abstract][Full Text] [Related]
13. The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy. Peters FT; Kuipers EJ; Ganesh S; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH Aliment Pharmacol Ther; 1999 Jul; 13(7):921-6. PubMed ID: 10383527 [TBL] [Abstract][Full Text] [Related]
14. [Factors and clinical forms of gastroesophageal reflux disease in adults]. Ropert A; Brochard C Rev Prat; 2016 Dec; 66(10):1080-1083. PubMed ID: 30512470 [TBL] [Abstract][Full Text] [Related]
15. Pathophysiology of gastro-oesophageal reflux disease. De Giorgi F; Palmiero M; Esposito I; Mosca F; Cuomo R Acta Otorhinolaryngol Ital; 2006 Oct; 26(5):241-6. PubMed ID: 17345925 [TBL] [Abstract][Full Text] [Related]
16. Gastro-oesophageal reflux during 3 months of therapy with ranitidine in reflux oesophagitis. Hatlebakk JG; Berstad A Scand J Gastroenterol; 1996 Oct; 31(10):954-8. PubMed ID: 8898414 [TBL] [Abstract][Full Text] [Related]
17. Alterations confined to the gastro-oesophageal junction: the relationship between low LOSP, TLOSRs, hiatus hernia and acid pocket. Boeckxstaens GE Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):821-9. PubMed ID: 21126696 [TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomic issues of the treatment of gastroesophageal reflux disease. Storr M; Meining A; Allescher HD Expert Opin Pharmacother; 2001 Jul; 2(7):1099-108. PubMed ID: 11583061 [TBL] [Abstract][Full Text] [Related]
19. New developments in the pathophysiology of gastro-oesophageal reflux disease (GERD): implications for patient management. Quigley EM Aliment Pharmacol Ther; 2003 Jun; 17 Suppl 2():43-51. PubMed ID: 12786612 [TBL] [Abstract][Full Text] [Related]
20. Rationale for high-dose H2-receptor blockade in the treatment of gastro-oesophageal reflux disease. Castell DO Aliment Pharmacol Ther; 1991; 5 Suppl 1():59-67. PubMed ID: 1679673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]